Cargando…
Patient journey for hypertension and dyslipidemia in Saudi Arabia: highlighting the evidence gaps
BACKGROUND: In recent years, Saudi Arabia has witnessed staggering rates of hypertension and dyslipidemia-related cardiovascular (CV) deaths, overburdening the healthcare ecosystem of the country. Appropriate public health interventions can be devised through quantitative mapping of evidence. Identi...
Autores principales: | Amir, Ashraf, Alasnag, Mirvat, Al-Raddadi, Rajaa, Al-Bassam, Tawfik, Saeed, Kanwal, Yazıcıoğlu, Mehmet, Shabana, Ayman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316580/ https://www.ncbi.nlm.nih.gov/pubmed/37400868 http://dx.doi.org/10.1186/s13690-023-01121-3 |
Ejemplares similares
-
2022 Saudi Guidelines for the Management of Dyslipidemia
por: AlRahimi, Jamilah, et al.
Publicado: (2023) -
The Association Between Prediabetes and Dyslipidemia Among Attendants of Primary Care Health Centers in Jeddah, Saudi Arabia
por: Al Amri, Turki, et al.
Publicado: (2019) -
Improvement initiative in LDL-C management in Saudi Arabia: A call to action()
por: Alasnag, Mirvat, et al.
Publicado: (2020) -
A semi-systematic review on hypertension and dyslipidemia care in Egypt—highlighting evidence gaps and recommendations for better patient outcomes
por: Reda, Ashraf, et al.
Publicado: (2021) -
Perceived COVID-19 Severity, Risk of Infection, and Prevention Self-Efficacy in Saudi Arabia During Lockdown: A Population-Based National Study
por: Al-Raddadi, Rajaa, et al.
Publicado: (2023)